Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

MND Scotland starts new trial of Interleukin-2 for ALS

New trial is launched to test Interleukin-2 for the treatment of motor neurone disease. Credit: Euan MacDonald Centre.

Go Top